PathExpSurv:用于解释性生存分析和疾病基因发现的途径扩展
Zhichao Hou1,2, Jiacheng Leng1,2, Jiating Yu1,2
1IAM, MADIS, NCMIS, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China.
BMC bioinformatics
|November 16, 2023
概括
通过整合已知的生物途径和发现新的途径,PathExpSurv增强了癌症生存分析. 这种可解释的神经网络方法有助于医学诊断和生物研究.
科学领域:
- 计算生物学是一种计算生物学.
- 生物信息学是一种生物信息学.
- 机器学习在医学中的应用
背景情况:
- 解释性和准确性对于生物学和医学预测模型至关重要.
- 神经网络的解释性仍然是一个重大挑战.
- 之前的生物学知识,就像路径一样,提高了模型的解释性,但可能是不完整的.
研究的目的:
- 开发一种可解释的神经网络方法,用于癌症生存率分析.
- 结合已知的生物途径并探索未知的途径扩展.
- 为了获得对黑盒模型的洞察力,以改善医疗诊断.
主要方法:
- 提出PathExpSurv,一种用于癌症生存率分析的新方法.
- 将已知的先前生物信息集成到神经网络模型中.
- 探索了对现有生物通路的潜在扩展.
主要成果:
- PathExpSurv成功地将已知路径信息纳入其中.
- 该方法确定了未知的路径扩展.
- 下游分析揭示了与疾病和途径相关的关键基因.
结论:
- "PathExpSurv"是生存分析的有效和可解释的方法.
- 这种方法在医学诊断中具有显著的实用性.
- 为推动生物研究提供了一个有前途的框架.
更多相关视频
相关概念视频
Genome-wide Association Studies-GWAS
13.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.5K
Comparing the Survival Analysis of Two or More Groups
199
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
199
Cancer Survival Analysis
356
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
356


